_id
6918473d3c536f8df2317826
Ticker
ZLDAF
Name
Zelira Therapeutics Limited
Exchange
OTCQB
Address
101 St Georges Terrace, Perth, WA, Australia, 6000
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://zeliratx.com
Description
Zelira Therapeutics Limited, a biopharmaceutical company, engages in the research, development, and commercialization of cannabinoid-based medicines for the treatment of various medical conditions in Australia and the United States. It offers formulations under the HOPE brand in Australia, Washington, Pennsylvania, and Louisiana, as well as develops ZENIVOL, a cannabinoid drug for the treatment of chronic insomnia. The company also provides over the counter (OTC) products, including SprinJeneCBD, an oral care product; and acne treatment products under the RAF FIVE name, as well as Zyraydi, an enhanced distillate capture and dissolution matrix technology. In addition, it offers products for autism and chronic noncancer pain. The company was formerly known as Zelda Therapeutics Limited and changed its name to Zelira Therapeutics Limited in December 2019. Zelira Therapeutics Limited was incorporated in 2003 and is based in Perth, Australia.
Last Close
0.2716
Volume
-
Current Price
0.2716
Change
13.94302848575713
Last Updated
2026-01-08T13:22:06.309Z
Image
https://logo.clearbit.com/zeliratx.com
Ipo Date
-
Market Cap
3752543
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2023-06-30
Revenue
-
Cost Of Revenue
-
Gross Profit
-
Operating Expenses
-
Operating Income
-
Interest Expense
-
Pretax Income
-
Net Income
-
Eps
-
Dividends Per Share
-
Shares Outstanding
11897155
Income Tax Expense
-
EBITDA
-
Operating Margin
-
Total Other Income Expense Net
-
Cash
146206
Short Term Investments
-
Receivables
-1092
Inventories
1527995
Total Current Assets
1770940
Property Plant Equipment
518745
Total Assets
33890713
Payables
1741011
Short Term Debt
-
Long Term Debt
-
Total Liabilities
2178913
Equity
31802072
Bs_currency_symbol
USD
Depreciation
135375
Change In Working Capital
-
Cash From Operations
-1822243
Capital Expenditures
0
Cash From Investing
939618
Cash From Financing
885020
Net Change In Cash
6208
Cf_currency_symbol
USD
PE
-
PB
0.09690838062375307
ROE
-
ROA
-
FCF
-1822243
Fcf Percent
-
Piotroski FScore
0
Health Score
59
Deep Value Investing Score
5
Defensive Investing Score
5.5
Dividend Investing Score
1.5
Economic Moat Investing Score
2.5
Garp Investing Score
1.5
Growth Investing Score
0
Momentum Investing Score
2
Net Net Investing Score
2.5
Quality Investing Score
2
Value Investing Score
5
Quarters > 0 > quarter
2023-06-30
Quarters > 0 > income Statement > revenue
-
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
-
Quarters > 0 > income Statement > operating Expenses
-
Quarters > 0 > income Statement > operating Income
-
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-
Quarters > 0 > income Statement > net Income
-
Quarters > 0 > income Statement > eps
-
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
11347155
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
-
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
146206
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
-1092
Quarters > 0 > balance Sheet > inventories
1527995
Quarters > 0 > balance Sheet > total Current Assets
1770940
Quarters > 0 > balance Sheet > property Plant Equipment
518745
Quarters > 0 > balance Sheet > total Assets
33890713
Quarters > 0 > balance Sheet > payables
1741011
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
2178913
Quarters > 0 > balance Sheet > equity
31802072
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-1147820
Quarters > 0 > cash Flow > depreciation
135375
Quarters > 0 > cash Flow > change In Working Capital
-
Quarters > 0 > cash Flow > cash From Operations
-1822243
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
939618
Quarters > 0 > cash Flow > cash From Financing
885020
Quarters > 0 > cash Flow > net Change In Cash
6208
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-
Quarters > 0 > ratios > PB
0.09690838062375307
Quarters > 0 > ratios > ROE
-
Quarters > 0 > ratios > ROA
-
Quarters > 0 > ratios > FCF
-1822243
Quarters > 0 > ratios > Piotroski FScore
0
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
59
Quarters > 1 > quarter
2023-03-31
Quarters > 1 > income Statement > revenue
-
Quarters > 1 > income Statement > cost Of Revenue
-
Quarters > 1 > income Statement > gross Profit
-
Quarters > 1 > income Statement > operating Expenses
-
Quarters > 1 > income Statement > operating Income
-
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-
Quarters > 1 > income Statement > net Income
-
Quarters > 1 > income Statement > eps
-
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
-
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
-
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
-
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
-1092
Quarters > 1 > balance Sheet > inventories
1527995
Quarters > 1 > balance Sheet > total Current Assets
1770940
Quarters > 1 > balance Sheet > property Plant Equipment
518745
Quarters > 1 > balance Sheet > total Assets
-
Quarters > 1 > balance Sheet > payables
1741011
Quarters > 1 > balance Sheet > short Term Debt
-
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
1883539
Quarters > 1 > balance Sheet > equity
-
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-1147820
Quarters > 1 > cash Flow > depreciation
135375
Quarters > 1 > cash Flow > change In Working Capital
-
Quarters > 1 > cash Flow > cash From Operations
-1822243
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
939618
Quarters > 1 > cash Flow > cash From Financing
885020
Quarters > 1 > cash Flow > net Change In Cash
6208
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-
Quarters > 1 > ratios > PB
-
Quarters > 1 > ratios > ROE
-
Quarters > 1 > ratios > ROA
-
Quarters > 1 > ratios > FCF
-1822243
Quarters > 1 > ratios > Piotroski FScore
0
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
45
Quarters > 2 > quarter
2022-12-31
Quarters > 2 > income Statement > revenue
-
Quarters > 2 > income Statement > cost Of Revenue
-
Quarters > 2 > income Statement > gross Profit
-
Quarters > 2 > income Statement > operating Expenses
-
Quarters > 2 > income Statement > operating Income
-
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-
Quarters > 2 > income Statement > net Income
-
Quarters > 2 > income Statement > eps
-
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
-
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
-
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
-
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
783460
Quarters > 2 > balance Sheet > inventories
1708595
Quarters > 2 > balance Sheet > total Current Assets
2625845
Quarters > 2 > balance Sheet > property Plant Equipment
703835
Quarters > 2 > balance Sheet > total Assets
-
Quarters > 2 > balance Sheet > payables
2127461
Quarters > 2 > balance Sheet > short Term Debt
-
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
2260749
Quarters > 2 > balance Sheet > equity
-
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-1638684
Quarters > 2 > cash Flow > depreciation
137237
Quarters > 2 > cash Flow > change In Working Capital
-
Quarters > 2 > cash Flow > cash From Operations
-1802296
Quarters > 2 > cash Flow > capital Expenditures
0
Quarters > 2 > cash Flow > cash From Investing
475000
Quarters > 2 > cash Flow > cash From Financing
885020
Quarters > 2 > cash Flow > net Change In Cash
-1306310
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-
Quarters > 2 > ratios > PB
-
Quarters > 2 > ratios > ROE
-
Quarters > 2 > ratios > ROA
-
Quarters > 2 > ratios > FCF
-1802296
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
45
Quarters > 3 > quarter
2022-09-30
Quarters > 3 > income Statement > revenue
-
Quarters > 3 > income Statement > cost Of Revenue
-
Quarters > 3 > income Statement > gross Profit
-
Quarters > 3 > income Statement > operating Expenses
-
Quarters > 3 > income Statement > operating Income
-
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-
Quarters > 3 > income Statement > net Income
-
Quarters > 3 > income Statement > eps
-
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
-
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-
Quarters > 3 > income Statement > operating Margin
-
Quarters > 3 > income Statement > total Other Income Expense Net
-
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
-
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
783460
Quarters > 3 > balance Sheet > inventories
1708595
Quarters > 3 > balance Sheet > total Current Assets
2625845
Quarters > 3 > balance Sheet > property Plant Equipment
703835
Quarters > 3 > balance Sheet > total Assets
-
Quarters > 3 > balance Sheet > payables
2127461
Quarters > 3 > balance Sheet > short Term Debt
-
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
2260749
Quarters > 3 > balance Sheet > equity
-
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-1638684
Quarters > 3 > cash Flow > depreciation
137237
Quarters > 3 > cash Flow > change In Working Capital
-
Quarters > 3 > cash Flow > cash From Operations
-1802296
Quarters > 3 > cash Flow > capital Expenditures
0
Quarters > 3 > cash Flow > cash From Investing
475000
Quarters > 3 > cash Flow > cash From Financing
885020
Quarters > 3 > cash Flow > net Change In Cash
-1306310
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-
Quarters > 3 > ratios > PB
-
Quarters > 3 > ratios > ROE
-
Quarters > 3 > ratios > ROA
-
Quarters > 3 > ratios > FCF
-1802296
Quarters > 3 > ratios > Piotroski FScore
0
Quarters > 3 > ratios > fcf Percent
-
Quarters > 3 > health Score
45
Annuals > 0 > quarter
2025-06-30
Annuals > 0 > income Statement > revenue
656
Annuals > 0 > income Statement > cost Of Revenue
8826
Annuals > 0 > income Statement > gross Profit
-8170
Annuals > 0 > income Statement > operating Expenses
-
Annuals > 0 > income Statement > operating Income
-3809463
Annuals > 0 > income Statement > interest Expense
407213
Annuals > 0 > income Statement > pretax Income
-3849672
Annuals > 0 > income Statement > net Income
-3627872
Annuals > 0 > income Statement > eps
-0.30493609606666466
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
11897155
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-
Annuals > 0 > income Statement > operating Margin
-580710.8231707317
Annuals > 0 > income Statement > total Other Income Expense Net
367004
Annuals > 0 > income Statement > currency_symbol
AUD
Annuals > 0 > balance Sheet > cash
5663
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
4687
Annuals > 0 > balance Sheet > inventories
477913
Annuals > 0 > balance Sheet > total Current Assets
614366
Annuals > 0 > balance Sheet > property Plant Equipment
121850
Annuals > 0 > balance Sheet > total Assets
1300695
Annuals > 0 > balance Sheet > payables
3449577
Annuals > 0 > balance Sheet > short Term Debt
-
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
5591017
Annuals > 0 > balance Sheet > equity
-4460428
Annuals > 0 > balance Sheet > currency_symbol
AUD
Annuals > 0 > cash Flow > net Income
-3627872
Annuals > 0 > cash Flow > depreciation
-
Annuals > 0 > cash Flow > change In Working Capital
-
Annuals > 0 > cash Flow > cash From Operations
-
Annuals > 0 > cash Flow > capital Expenditures
0
Annuals > 0 > cash Flow > cash From Investing
-
Annuals > 0 > cash Flow > cash From Financing
3189582
Annuals > 0 > cash Flow > net Change In Cash
-564493
Annuals > 0 > cash Flow > currency_symbol
AUD
Annuals > 0 > ratios > PE
-0.30493609606666466
Annuals > 0 > ratios > PB
-0.7244298748909298
Annuals > 0 > ratios > ROE
81.33461631933079
Annuals > 0 > ratios > ROA
-278.917963088964
Annuals > 0 > ratios > FCF
-
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
38
Annuals > 1 > quarter
2024-06-30
Annuals > 1 > income Statement > revenue
94952
Annuals > 1 > income Statement > cost Of Revenue
84668
Annuals > 1 > income Statement > gross Profit
10284
Annuals > 1 > income Statement > operating Expenses
-
Annuals > 1 > income Statement > operating Income
-5938230
Annuals > 1 > income Statement > interest Expense
739272
Annuals > 1 > income Statement > pretax Income
-36739759
Annuals > 1 > income Statement > net Income
-36568904
Annuals > 1 > income Statement > eps
-3.2227376818242104
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
11347155
Annuals > 1 > income Statement > income Tax Expense
-
Annuals > 1 > income Statement > EBITDA
-
Annuals > 1 > income Statement > operating Margin
-6253.928300615048
Annuals > 1 > income Statement > total Other Income Expense Net
-30062566
Annuals > 1 > income Statement > currency_symbol
AUD
Annuals > 1 > balance Sheet > cash
586161
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
12991
Annuals > 1 > balance Sheet > inventories
1252311
Annuals > 1 > balance Sheet > total Current Assets
4260233
Annuals > 1 > balance Sheet > property Plant Equipment
225208
Annuals > 1 > balance Sheet > total Assets
5183417
Annuals > 1 > balance Sheet > payables
3407452
Annuals > 1 > balance Sheet > short Term Debt
-
Annuals > 1 > balance Sheet > long Term Debt
2113527
Annuals > 1 > balance Sheet > total Liabilities
9356587
Annuals > 1 > balance Sheet > equity
-4514925
Annuals > 1 > balance Sheet > currency_symbol
AUD
Annuals > 1 > cash Flow > net Income
-36568904
Annuals > 1 > cash Flow > depreciation
-
Annuals > 1 > cash Flow > change In Working Capital
-
Annuals > 1 > cash Flow > cash From Operations
-
Annuals > 1 > cash Flow > capital Expenditures
0
Annuals > 1 > cash Flow > cash From Investing
-
Annuals > 1 > cash Flow > cash From Financing
3924034
Annuals > 1 > cash Flow > net Change In Cash
455179
Annuals > 1 > cash Flow > currency_symbol
AUD
Annuals > 1 > ratios > PE
-3.2227376818242104
Annuals > 1 > ratios > PB
-0.6825998877057758
Annuals > 1 > ratios > ROE
809.9559571864427
Annuals > 1 > ratios > ROA
-705.4980141478103
Annuals > 1 > ratios > FCF
-
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
38
Annuals > 2 > quarter
2023-06-30
Annuals > 2 > income Statement > revenue
301121
Annuals > 2 > income Statement > cost Of Revenue
362560
Annuals > 2 > income Statement > gross Profit
-61439
Annuals > 2 > income Statement > operating Expenses
-
Annuals > 2 > income Statement > operating Income
-7263130
Annuals > 2 > income Statement > interest Expense
76661
Annuals > 2 > income Statement > pretax Income
-6268732
Annuals > 2 > income Statement > net Income
-5573007
Annuals > 2 > income Statement > eps
-0.4911369413742916
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
11347155
Annuals > 2 > income Statement > income Tax Expense
-
Annuals > 2 > income Statement > EBITDA
-5646847
Annuals > 2 > income Statement > operating Margin
-2412.0303798140944
Annuals > 2 > income Statement > total Other Income Expense Net
1070925
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
146206
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
-8648
Annuals > 2 > balance Sheet > inventories
1527995
Annuals > 2 > balance Sheet > total Current Assets
1770940
Annuals > 2 > balance Sheet > property Plant Equipment
518745
Annuals > 2 > balance Sheet > total Assets
33890713
Annuals > 2 > balance Sheet > payables
1741011
Annuals > 2 > balance Sheet > short Term Debt
-
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
2178913
Annuals > 2 > balance Sheet > equity
31802072
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-5573007
Annuals > 2 > cash Flow > depreciation
545224
Annuals > 2 > cash Flow > change In Working Capital
-
Annuals > 2 > cash Flow > cash From Operations
-7249078
Annuals > 2 > cash Flow > capital Expenditures
0
Annuals > 2 > cash Flow > cash From Investing
2829235
Annuals > 2 > cash Flow > cash From Financing
1770039
Annuals > 2 > cash Flow > net Change In Cash
-2600203
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-0.4911369413742916
Annuals > 2 > ratios > PB
0.09690838062375307
Annuals > 2 > ratios > ROE
-17.524037427498435
Annuals > 2 > ratios > ROA
-16.44405356712324
Annuals > 2 > ratios > FCF
-7249078
Annuals > 2 > ratios > Piotroski FScore
1
Annuals > 2 > ratios > fcf Percent
-24.073638172030513
Annuals > 2 > health Score
34
Annuals > 3 > quarter
2022-06-30
Annuals > 3 > income Statement > revenue
1540624
Annuals > 3 > income Statement > cost Of Revenue
939054
Annuals > 3 > income Statement > gross Profit
601570
Annuals > 3 > income Statement > operating Expenses
-
Annuals > 3 > income Statement > operating Income
-13645457
Annuals > 3 > income Statement > interest Expense
53848
Annuals > 3 > income Statement > pretax Income
-12413518
Annuals > 3 > income Statement > net Income
-11945303
Annuals > 3 > income Statement > eps
-1.2472755890186566
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
9577116
Annuals > 3 > income Statement > income Tax Expense
-
Annuals > 3 > income Statement > EBITDA
-11771127
Annuals > 3 > income Statement > operating Margin
-885.7097513734695
Annuals > 3 > income Statement > total Other Income Expense Net
1275192
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
2746409
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
101430
Annuals > 3 > balance Sheet > inventories
1957147
Annuals > 3 > balance Sheet > total Current Assets
5076146
Annuals > 3 > balance Sheet > property Plant Equipment
847632
Annuals > 3 > balance Sheet > total Assets
37701491
Annuals > 3 > balance Sheet > payables
1510045
Annuals > 3 > balance Sheet > short Term Debt
-
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
2010953
Annuals > 3 > balance Sheet > equity
35203153
Annuals > 3 > balance Sheet > currency_symbol
AUD
Annuals > 3 > cash Flow > net Income
-11945303
Annuals > 3 > cash Flow > depreciation
588543
Annuals > 3 > cash Flow > change In Working Capital
-
Annuals > 3 > cash Flow > cash From Operations
-9427224
Annuals > 3 > cash Flow > capital Expenditures
0
Annuals > 3 > cash Flow > cash From Investing
-207782
Annuals > 3 > cash Flow > cash From Financing
7099594
Annuals > 3 > cash Flow > net Change In Cash
-2224707
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-1.2472755890186566
Annuals > 3 > ratios > PB
0.07388953783770448
Annuals > 3 > ratios > ROE
-33.932480422989386
Annuals > 3 > ratios > ROA
-31.683900777292866
Annuals > 3 > ratios > FCF
-9427224
Annuals > 3 > ratios > Piotroski FScore
1
Annuals > 3 > ratios > fcf Percent
-6.119094600629356
Annuals > 3 > health Score
34
Valuation > metrics > PB
0.09690838062375307
Valuation > final Score
70
Valuation > verdict
90.3% Undervalued
Profitability > final Score
50
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.06851481249397838
Risk > final Score
80
Risk > verdict
Low
Liquidity > metrics > Current Ratio
1.0171905863891728
Liquidity > metrics > Quick Ratio
0.1395424842232473
Liquidity > final Score
32
Liquidity > verdict
Weak
Prev Valuations > 0
50
Prev Valuations > 1
50
Prev Valuations > 2
50
Prev Profitabilities > 0
50
Prev Profitabilities > 1
50
Prev Profitabilities > 2
50
Prev Risks > 0
50
Prev Risks > 1
50
Prev Risks > 2
50
Prev Liquidities > 0
32
Prev Liquidities > 1
52
Prev Liquidities > 2
52
Updated At
2026-01-20T22:51:56.445Z
Earnings History > 0 > period
2025-12-31
Earnings History > 0 > report Date
2026-02-24
Earnings History > 0 > date
2025-12-31
Earnings History > 0 > before After Market
BeforeMarket
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2021-03-31
Earnings History > 1 > report Date
2021-06-30
Earnings History > 1 > date
2021-03-31
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
USD
Earnings History > 1 > eps Actual
-0.0015
Earnings History > 1 > eps Estimate
0
Earnings History > 1 > eps Difference
-0.0015
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2020-12-31
Earnings History > 2 > report Date
2021-03-31
Earnings History > 2 > date
2020-12-31
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
USD
Earnings History > 2 > eps Actual
-0.0015
Earnings History > 2 > eps Estimate
0
Earnings History > 2 > eps Difference
-0.0015
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2020-09-30
Earnings History > 3 > report Date
2020-12-31
Earnings History > 3 > date
2020-09-30
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
USD
Earnings History > 3 > eps Actual
-0.0013
Earnings History > 3 > eps Estimate
0
Earnings History > 3 > eps Difference
-0.0013
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2020-06-30
Earnings History > 4 > report Date
2020-09-30
Earnings History > 4 > date
2020-06-30
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-0.0012
Earnings History > 4 > eps Estimate
0
Earnings History > 4 > eps Difference
-0.0012
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2020-03-31
Earnings History > 5 > report Date
2020-06-30
Earnings History > 5 > date
2020-03-31
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.0016
Earnings History > 5 > eps Estimate
0
Earnings History > 5 > eps Difference
-0.0016
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2019-12-31
Earnings History > 6 > report Date
2020-03-31
Earnings History > 6 > date
2019-12-31
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.0015
Earnings History > 6 > eps Estimate
0
Earnings History > 6 > eps Difference
-0.0015
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2019-09-30
Earnings History > 7 > report Date
2019-12-31
Earnings History > 7 > date
2019-09-30
Earnings History > 7 > before After Market
-
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.0012
Earnings History > 7 > eps Estimate
0
Earnings History > 7 > eps Difference
-0.0012
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2019-06-30
Earnings History > 8 > report Date
2019-09-30
Earnings History > 8 > date
2019-06-30
Earnings History > 8 > before After Market
-
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.0011
Earnings History > 8 > eps Estimate
0
Earnings History > 8 > eps Difference
-0.0011
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2019-03-31
Earnings History > 9 > report Date
2019-06-30
Earnings History > 9 > date
2019-03-31
Earnings History > 9 > before After Market
-
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.0007
Earnings History > 9 > eps Estimate
0
Earnings History > 9 > eps Difference
-0.0007
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2018-12-31
Earnings History > 10 > report Date
2019-03-31
Earnings History > 10 > date
2018-12-31
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.0007
Earnings History > 10 > eps Estimate
0
Earnings History > 10 > eps Difference
-0.0007
Earnings History > 10 > surprise Percent
-
Earnings History > 11 > period
2018-09-30
Earnings History > 11 > report Date
2018-12-31
Earnings History > 11 > date
2018-09-30
Earnings History > 11 > before After Market
-
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.001
Earnings History > 11 > eps Estimate
0
Earnings History > 11 > eps Difference
-0.001
Earnings History > 11 > surprise Percent
-
Earnings History > 12 > period
2018-06-30
Earnings History > 12 > report Date
2018-09-30
Earnings History > 12 > date
2018-06-30
Earnings History > 12 > before After Market
-
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.001
Earnings History > 12 > eps Estimate
0
Earnings History > 12 > eps Difference
-0.001
Earnings History > 12 > surprise Percent
-
Earnings History > 13 > period
2018-03-31
Earnings History > 13 > report Date
2018-06-30
Earnings History > 13 > date
2018-03-31
Earnings History > 13 > before After Market
-
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-0.0006
Earnings History > 13 > eps Estimate
0
Earnings History > 13 > eps Difference
-0.0006
Earnings History > 13 > surprise Percent
-
Earnings History > 14 > period
2017-12-31
Earnings History > 14 > report Date
2018-03-31
Earnings History > 14 > date
2017-12-31
Earnings History > 14 > before After Market
-
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-0.0006
Earnings History > 14 > eps Estimate
0
Earnings History > 14 > eps Difference
-0.0006
Earnings History > 14 > surprise Percent
-
Earnings History > 15 > period
2017-09-30
Earnings History > 15 > report Date
2017-12-31
Earnings History > 15 > date
2017-09-30
Earnings History > 15 > before After Market
-
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-0.0003
Earnings History > 15 > eps Estimate
0
Earnings History > 15 > eps Difference
-0.0003
Earnings History > 15 > surprise Percent
-
Earnings History > 16 > period
2017-06-30
Earnings History > 16 > report Date
2017-09-30
Earnings History > 16 > date
2017-06-30
Earnings History > 16 > before After Market
-
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
-0.0003
Earnings History > 16 > eps Estimate
0
Earnings History > 16 > eps Difference
-0.0003
Earnings History > 16 > surprise Percent
-
Earnings History > 17 > period
2017-03-31
Earnings History > 17 > report Date
2017-06-30
Earnings History > 17 > date
2017-03-31
Earnings History > 17 > before After Market
-
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
-0.0006
Earnings History > 17 > eps Estimate
0
Earnings History > 17 > eps Difference
-0.0006
Earnings History > 17 > surprise Percent
-
Earnings History > 18 > period
2016-12-31
Earnings History > 18 > report Date
2017-03-31
Earnings History > 18 > date
2016-12-31
Earnings History > 18 > before After Market
-
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
-0.0006
Earnings History > 18 > eps Estimate
0
Earnings History > 18 > eps Difference
-0.0006
Earnings History > 18 > surprise Percent
-
Earnings History > 19 > period
2016-09-30
Earnings History > 19 > report Date
2016-12-31
Earnings History > 19 > date
2016-09-30
Earnings History > 19 > before After Market
-
Earnings History > 19 > currency
USD
Earnings History > 19 > eps Actual
-0.0064
Earnings History > 19 > eps Estimate
0
Earnings History > 19 > eps Difference
-0.0064
Earnings History > 19 > surprise Percent
-
Earnings History > 20 > period
2016-06-30
Earnings History > 20 > report Date
2016-09-30
Earnings History > 20 > date
2016-06-30
Earnings History > 20 > before After Market
-
Earnings History > 20 > currency
USD
Earnings History > 20 > eps Actual
-0.0068
Earnings History > 20 > eps Estimate
0
Earnings History > 20 > eps Difference
-0.0068
Earnings History > 20 > surprise Percent
-
Zelira Therapeutics Limited, a biopharmaceutical company, engages in the research, development, and commercialization of cannabinoid-based medicines for the treatment of various medical conditions in Australia and the United States. It offers formulations under the HOPE brand in Australia, Washington, Pennsylvania, and Louisiana, as well as develops ZENIVOL, a cannabinoid drug for the treatment of chronic insomnia. The company also provides over the counter (OTC) products, including SprinJeneCBD, an oral care product; and acne treatment products under the RAF FIVE name, as well as Zyraydi, an enhanced distillate capture and dissolution matrix technology. In addition, it offers products for autism and chronic noncancer pain. The company was formerly known as Zelda Therapeutics Limited and changed its name to Zelira Therapeutics Limited in December 2019. Zelira Therapeutics Limited was incorporated in 2003 and is based in Perth, Australia.
Stock Price
$0.00
increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/A(Last Updated 2023-06-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Zelira Therapeutics Limited
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
—
Date
2021-03-31
EPS Actual
-0.0015
EPS Estimate
0
EPS Difference
-0.0015
Surprise Percent
0%
(Last Updated 2023-06-30)
(Last Updated 2023-06-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2023-06-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2023-06-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.